Open for recruitment
Trial summary
The ERASE study aims to develop a method for using Stereotactic Ablative Radiation Therapy (SABR) that accounts for both the anatomy (the shape and position of the cancer) and the biological response to immunotherapy and demonstrate that this approach is effective in treating metastatic melanoma.
Trial details
Short title
ERASE
Diagnosis
Skin cancer – melanoma
Type of treatment
Radiation Oncology
Phase
N/A
Locations
Who can participate
Clinical trials can have restrictive criteria of who can and can’t participate, talk to your healthcare provider if you are interested in this clinical trial.